Literature DB >> 14706340

Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability.

Hyun Jin Shin1, Kwan Hyuck Baek, Ae Hwa Jeon, Moon Taek Park, Su Jae Lee, Chang Mo Kang, Hyun Sook Lee, Seong Ho Yoo, Doo Hyun Chung, Young Chul Sung, Frank McKeon, Chang Woo Lee.   

Abstract

In this study, we show that the formation of polyploidy following sustained mitotic checkpoint activation appears to be preceded by the ubiquitin-dependent proteolysis of hBubR1. In addition, the level of hBubR1 is significantly reduced not only in polyploid cells created by sustained mitotic spindle damage, but also in 21 (31.3%) of 67 human colon adenocarcinomas tested. Importantly, the introduction of hBubR1 triggers the apoptosis of polyploid cells formed by aberrant exit from mitosis and inhibits the growth of tumors established with these cells in athymic nude mice. These results suggest that hBubR1-mediated apoptosis prevents the propagation of cells that breach the mitotic checkpoint and that the control of hBubR1 protein level is an important factor in the acquisition of preneoplastic polyploidy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14706340     DOI: 10.1016/s1535-6108(03)00302-7

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  59 in total

1.  Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization.

Authors:  Zilai Zhang; Sumit Arora; Yanjiao Zhou; Athena Cherry; Teresa S-F Wang
Journal:  Chromosoma       Date:  2010-09-09       Impact factor: 4.316

Review 2.  Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.

Authors:  Conly L Rieder
Journal:  Chromosome Res       Date:  2011-04       Impact factor: 5.239

3.  Mitotic checkpoint function in the formation of gross chromosomal rearrangements in Saccharomyces cerevisiae.

Authors:  Kyungjae Myung; Stephanie Smith; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-28       Impact factor: 11.205

4.  Apoptosis regulation in tetraploid cancer cells.

Authors:  Maria Castedo; Arnaud Coquelle; Sonia Vivet; Ilio Vitale; Audrey Kauffmann; Philippe Dessen; Marie O Pequignot; Noelia Casares; Alexandre Valent; Shahul Mouhamad; Elise Schmitt; Nazanine Modjtahedi; William Vainchenker; Laurence Zitvogel; Vladimir Lazar; Carmen Garrido; Guido Kroemer
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

Review 5.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

6.  Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.

Authors:  Varvara Trachana; Karel H M van Wely; Astrid Alonso Guerrero; Agnes Fütterer; Carlos Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

7.  Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisons.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-01       Impact factor: 6.261

8.  BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy.

Authors:  Dominik Schnerch; Andrea Schmidts; Marie Follo; Josefina Udi; Julia Felthaus; Dietmar Pfeifer; Monika Engelhardt; Ralph Wäsch
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

9.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.